Aging Versus Postmenopausal Osteoporosis: Bone Composition and Maturation Kinetics at Actively-Forming Trabecular Surfaces of Female Subjects Aged 1 to 84 Years.
about
Advanced Glycation Endproducts and Bone Material Properties in Type 1 Diabetic MiceEffect of anti-sclerostin therapy and osteogenesis imperfecta on tissue-level properties in growing and adult mice while controlling for tissue age.Region specific Raman spectroscopy analysis of the femoral head reveals that trabecular bone is unlikely to contribute to non-traumatic osteonecrosisMaxillary Sinus Lift with Beta-Tricalcium Phosphate (β-TCP) in Edentulous Patients: A Nanotomographic and Raman Study.Post-yield and failure properties of cortical bone.Vibrational spectroscopic techniques to assess bone quality.Do we need orthogeriatrics in Poland? Changes in the age structure and location of hip fractures.Short-term and long-term effects of osteoporosis on incisor teeth and femoral bones evaluated by Raman spectroscopy and energy dispersive X-ray analysis in ovariectomized rats.Phenotypic Spectrum in Osteogenesis Imperfecta Due to Mutations in TMEM38B: Unraveling a Complex Cellular Defect.Bone quality changes associated with aging and disease: a review.Identification of Pyridinoline Trivalent Collagen Cross-Links by Raman Microspectroscopy.Evidence for a Role for Nanoporosity and Pyridinoline Content in Human Mild Osteogenesis Imperfecta.Fragility Fracture Incidence in Chronic Obstructive Pulmonary Disease (COPD) Patients Associates With Nanoporosity, Mineral/Matrix Ratio, and Pyridinoline Content at Actively Bone-Forming Trabecular Surfaces.Clinical characteristics associated with bone mineral density improvement after 1-year alendronate/vitamin d3 or calcitriol treatment: Exploratory results from a phase 3, randomized, controlled trial on postmenopausal osteoporotic women in China
P2860
Q28551744-DAAB8368-94E1-4E49-BD49-C53C885CCCA4Q30713102-FD120068-40F8-4DC9-9D54-67C90FE17C12Q33668876-3897560A-5735-41F0-B686-A6111CB5AFAEQ36356644-960C9956-FAC1-4503-B049-07163A31A0CEQ38942134-3115AE46-9261-40DA-AD35-81E72E085B1BQ39220959-2EADDAD9-6781-4427-BE98-77C57A661DC1Q40592675-182A3109-54E4-43D8-AC21-564FDE93B563Q47551929-8DF28BC0-CE38-4AE0-B937-C6DC42052E8CQ51092170-5F5DEB69-2147-4010-8E78-5722039CC9EAQ51751793-ABACC256-4AD3-4518-947E-3CD6F907FCDEQ52899898-D20061F1-56B4-4ECD-A497-F02ABCDB9EC9Q53215245-956DDE9C-7AC3-4079-ABD7-F14DFE57C078Q53704026-742A09FF-EB35-4B84-A722-3C6FA5BE63D4Q58802020-6F7130D3-798F-4272-A6C7-D4D804788064
P2860
Aging Versus Postmenopausal Osteoporosis: Bone Composition and Maturation Kinetics at Actively-Forming Trabecular Surfaces of Female Subjects Aged 1 to 84 Years.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Aging Versus Postmenopausal Os ...... e Subjects Aged 1 to 84 Years.
@en
Aging Versus Postmenopausal Os ...... e Subjects Aged 1 to 84 Years.
@nl
type
label
Aging Versus Postmenopausal Os ...... e Subjects Aged 1 to 84 Years.
@en
Aging Versus Postmenopausal Os ...... e Subjects Aged 1 to 84 Years.
@nl
prefLabel
Aging Versus Postmenopausal Os ...... e Subjects Aged 1 to 84 Years.
@en
Aging Versus Postmenopausal Os ...... e Subjects Aged 1 to 84 Years.
@nl
P2093
P2860
P50
P356
P1476
Aging Versus Postmenopausal Os ...... e Subjects Aged 1 to 84 Years.
@en
P2093
David Dempster
Eleftherios P Paschalis
Elizabeth Shane
Erik F Eriksen
Francis H Glorieux
Klaus Klaushofer
Norbert Hassler
Robert Recker
Wolfgang Brozek
P2860
P304
P356
10.1002/JBMR.2696
P577
2015-08-26T00:00:00Z